Clinical Impact of Revised Cefepime Breakpoint in Patients With Enterobacteriaceae Bacteremia

The impact of the revised Clinical and Laboratory Standards Institute interpretative criteria for cefepime in Enterobacteriaceae remains unclear. We applied the new breakpoint on 644 previously defined cefepime-susceptible Enterobacteriaceae isolates. We found no differences in mortality or microbio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Foong, Kap Sum, Carlson, Abigail L, Munigala, Satish, Burnham, Carey-Ann D, Warren, David K
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735685/
https://ncbi.nlm.nih.gov/pubmed/31660387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz341
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars